Literature DB >> 1452076

Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand.

J R Jass1, P J Young, E M Robinson.   

Abstract

Three hundred and thirty six forensic necropsy specimens of large bowel were examined in order to identify subject related variables that independently predicted the following adenoma characteristics: presence, size (largest), multiplicity and high grade dysplasia. The variables were age, gender, body mass index, race (European origin versus Maori/Polynesian) and presence of hyperplastic (metaplastic) polyp(s). Subjects included 303 New Zealanders of European origin (M = 185, F = 118) yielding 149 adenomas and 251 hyperplastic polyps and 33 Maori/Polynesians (M = 25, F = 8) yielding five adenomas and one hyperplastic polyp. Independent predictors of adenoma presence as determined by regression analysis were age (p = 0.0001), presence of hyperplastic polyps (p = 0.0001) and male gender (p = 0.05). Models were poor at explaining variation in size, multiplicity, and dysplasia. Larger adenomas occurred more frequently in subjects with multiple adenomas (p = 0.03) and multiple adenomas were probably associated with hyperplastic polyps (p = 0.09) and male gender (p = 0.09) in Europeans. High grade dysplasia was more frequent in women (p = 0.05) and possibly in subjects with hyperplastic polyps (p = 0.2). Body mass index and ethnicity did not predict any adenoma characteristics, but hyperplastic polyp prevalence was influenced by European origin (p = 0.04) and to a lesser extent by body mass index (p = 0.08) as well as presence of adenoma (p = 0.0002) and age ( = 0.005). The association of hyperplastic polyp with presence, multiplicity but not size of adenoma and with a high risk group for colorectal cancer (New Zealanders of European origin) suggests that the hyperplastic polyp serves as a marker for a factor which influences neoplastic evolution at the stages of initiation/transformation but not promotion. Fifty nine per cent of individuals with adenoma(s) did not have hyperplastic polyp(s) emphasising that the last would serve only as a marker of populations and not individuals at high risk of bowel cancer. Low intracolonic butyrate may be the factor linking the expression of the two types of polyp.

Entities:  

Mesh:

Year:  1992        PMID: 1452076      PMCID: PMC1379537          DOI: 10.1136/gut.33.11.1508

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  40 in total

1.  INCIDENCE AND DISTRIBUTION OF ADENOMATOUS POLYPS OF THE COLON AND RECTUM BASED ON 1,000 AUTOPSY EXAMINATIONS.

Authors:  T C ARMINSKI; D W MCLEAN
Journal:  Dis Colon Rectum       Date:  1964 Jul-Aug       Impact factor: 4.585

2.  Adenomatous polypi of large intestine: incidence and distribution.

Authors:  I CHAPMAN
Journal:  Ann Surg       Date:  1963-02       Impact factor: 12.969

Review 3.  Screening for colorectal cancer.

Authors:  D F Ransohoff; C A Lang
Journal:  N Engl J Med       Date:  1991-07-04       Impact factor: 91.245

4.  Structure and significance of metaplastic nodules in the rectal mucosa.

Authors:  J F Arthur
Journal:  J Clin Pathol       Date:  1968-11       Impact factor: 3.411

5.  The evolution of cancer of the colon and rectum.

Authors:  T Muto; H J Bussey; B C Morson
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

6.  Colonic fermentation of dietary fibre to short chain fatty acids in patients with adenomatous polyps and colonic cancer.

Authors:  M R Clausen; H Bonnén; P B Mortensen
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

7.  Adenomatous lesions of the large bowel: an autopsy survey.

Authors:  R R Rickert; O Auerbach; L Garfinkel; E C Hammond; J M Frasca
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

8.  Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate.

Authors:  C Augeron; C L Laboisse
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

9.  Definition, measurement, and classification of the syndromes of obesity.

Authors:  G A Bray
Journal:  Int J Obes       Date:  1978

10.  Hyperplastic (metaplastic) polyps of the colon. A histologic and histochemical study.

Authors:  G Frazin; G Zamboni; A Scarpa; R Dina; A Iannucci; P Novelli
Journal:  Am J Surg Pathol       Date:  1984-09       Impact factor: 6.394

View more
  52 in total

1.  Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.

Authors:  Amy B Knudsen; Iris Lansdorp-Vogelaar; Carolyn M Rutter; James E Savarino; Marjolein van Ballegooijen; Karen M Kuntz; Ann G Zauber
Journal:  J Natl Cancer Inst       Date:  2010-07-27       Impact factor: 13.506

2.  How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysis.

Authors:  Ulrike Haug; Amy B Knudsen; Karen M Kuntz
Journal:  Int J Cancer       Date:  2012-03-29       Impact factor: 7.396

3.  A genome wide linkage analysis in Swedish families with hereditary non-familial adenomatous polyposis/non-hereditary non-polyposis colorectal cancer.

Authors:  T Djureinovic; J Skoglund; J Vandrovcova; X-L Zhou; A Kalushkova; L Iselius; A Lindblom
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

4.  A hierarchical non-homogenous Poisson model for meta-analysis of adenoma counts.

Authors:  Carolyn M Rutter; Onchee Yu; Diana L Miglioretti
Journal:  Stat Med       Date:  2007-01-15       Impact factor: 2.373

5.  Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.

Authors:  David J Vanness; Amy B Knudsen; Iris Lansdorp-Vogelaar; Carolyn M Rutter; Ilana F Gareen; Benjamin A Herman; Karen M Kuntz; Ann G Zauber; Marjolein van Ballegooijen; Eric J Feuer; Mei-Hsiu Chen; C Daniel Johnson
Journal:  Radiology       Date:  2011-08-03       Impact factor: 11.105

6.  Nomenclature, molecular genetics and clinical significance of the precursor lesions in the serrated polyp pathway of colorectal carcinoma.

Authors:  John J Liang; Sadir Alrawi; Dongfeng Tan
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

7.  Metaplastic (hyperplastic) polyps of the large bowel: benign neoplasms after all?

Authors:  G T Williams
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

8.  Optimal colorectal cancer screening in states' low-income, uninsured populations—the case of South Carolina.

Authors:  Alex van der Steen; Amy B Knudsen; Frank van Hees; Gailya P Walter; Franklin G Berger; Virginie G Daguise; Karen M Kuntz; Ann G Zauber; Marjolein van Ballegooijen; Iris Lansdorp-Vogelaar
Journal:  Health Serv Res       Date:  2014-10-16       Impact factor: 3.402

9.  Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.

Authors:  Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Ann G Zauber; J Dik F Habbema; Ernst J Kuipers
Journal:  J Natl Cancer Inst       Date:  2009-09-24       Impact factor: 13.506

10.  High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.

Authors:  Reinier G S Meester; Iris Lansdorp-Vogelaar; Sidney J Winawer; Ann G Zauber; Amy B Knudsen; Uri Ladabaum
Journal:  Ann Intern Med       Date:  2019-09-24       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.